Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy

Journal of Clinical Oncology

Volumn 19, Issue 21, 2001, Pages 4126-4134

  Quirt, I ^a   Robeson, C ^a   Lau, C Y ^a   Kovacs, M ^a   Burdette Radoux, S ^a   Dolan, S ^a   Tang, S C ^a   McKenzie, M ^a   Couture, F ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; ASTHENIA; BACKACHE; BLOOD TRANSFUSION; CANADA; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; EDEMA; FATIGUE; FEMALE; FEVER; HEADACHE; HUMAN; MALE; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; VOMITING;

EID: 0035503198     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.21.4126     Document Type: Article

References (19)

1. Anemia of cancer
2. Clinical guidelines for the treatment of cancer-related anemia
3. Characterization and biological effects of recombinant human erythropoietin
4. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: Results of double-blind and open-label follow-up studies
5. Recombinant human erythropoietin (r-HuEPO) for the treatment of the anemia of cancer
6. Recombinant human erythropoietin therapy for anemic cancer on combination chemotherapy
7. Progress toward guidelines for the management of fatigue
8. Cancer-related fatigue: Guidelines for evaluation and management
9. Impact of cancer-related fatigue on the lives of patients
10. A Canadian survey of cancer patients' experiences: Are their needs being met?
11. The functional assessment of cancer therapy-anemia (FACT-An) scale: A new tool for the assessment of outcomes in cancer anemia and fatigue
12. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system
13. Factors influencing quality of life in cancer patients: Anemia and fatigue
14. Clinical applications of visual analog scales: A critical review
15. Assessment of the quality of life of patients with advanced cancer
16. Sensitivity and accuracy of the visual analogue scale: A psycho-physical classroom experiment
17. Assessing the clinical significance of changes in health-related quality-of-life (HRQOL) scores
18. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumour type: Results from a prospective community oncology study
19. Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice: Procrit Study Group